Medplus Health [MEDPLUS] vs Trident Lifeline [TLL] Detailed Stock Comparison
Medplus Health
NSE
Loading...
Trident Lifeline
BSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Medplus Health wins in 8 metrics, Trident Lifeline wins in 11 metrics, with 0 ties. Trident Lifeline appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Medplus Health | Trident Lifeline | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 54.22 | 25.39 | Trident Lifeline |
| Price-to-Book Ratio | 5.49 | 4.93 | Trident Lifeline |
| Debt-to-Equity Ratio | 64.36 | 77.58 | Medplus Health |
| PEG Ratio | 53.18 | 0.28 | Trident Lifeline |
| EV/EBITDA | 29.79 | 19.53 | Trident Lifeline |
| Profit Margin (TTM) | 2.88% | 13.27% | Trident Lifeline |
| Operating Margin (TTM) | 4.22% | 15.70% | Trident Lifeline |
| EBITDA Margin (TTM) | 4.22% | 15.70% | Trident Lifeline |
| Return on Equity | 8.64% | 16.87% | Trident Lifeline |
| Return on Assets (TTM) | 4.47% | 7.53% | Trident Lifeline |
| Free Cash Flow (TTM) | $4.81B | $-213.41M | Medplus Health |
| 1-Year Return | 26.72% | -1.27% | Medplus Health |
| Price-to-Sales Ratio (TTM) | 1.56 | 3.29 | Medplus Health |
| Enterprise Value | $103.80B | $3.46B | Medplus Health |
| EV/Revenue Ratio | 1.68 | 3.56 | Medplus Health |
| Gross Profit Margin (TTM) | 26.12% | 53.63% | Trident Lifeline |
| Revenue per Share (TTM) | $518 | $81 | Medplus Health |
| Earnings per Share (Diluted) | $14.83 | $10.90 | Medplus Health |
| Beta (Stock Volatility) | 0.69 | -0.16 | Trident Lifeline |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Medplus Health vs Trident Lifeline Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Medplus Health | 1.21% | -3.02% | -7.43% | -0.80% | 12.29% | -4.09% |
| Trident Lifeline | -5.56% | 0.65% | 3.67% | -4.88% | 4.85% | -2.54% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Medplus Health | 26.72% | 13.27% | -24.37% | -24.37% | -24.37% | -24.37% |
| Trident Lifeline | -1.27% | 117.78% | 117.78% | 117.78% | 117.78% | 117.78% |
Performance & Financial Health Analysis: Medplus Health vs Trident Lifeline
| Metric | MEDPLUS | TLL |
|---|---|---|
| Market Information | ||
| Market Cap | ₹96.37B | ₹3.21B |
| Market Cap Category | Mid cap | Small cap |
| 10 Day Avg. Volume | 358,057 | 14,220 |
| 90 Day Avg. Volume | 202,418 | 8,180 |
| Last Close | ₹813.80 | ₹276.80 |
| 52 Week Range | ₹616.00 - ₹1,045.30 | ₹222.00 - ₹339.00 |
| % from 52W High | -22.15% | -18.35% |
| All-Time High | ₹1,343.00 (Jan 17, 2022) | ₹339.00 (Sep 02, 2024) |
| % from All-Time High | -39.40% | -18.35% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.04% | 0.80% |
| Quarterly Earnings Growth | 1.95% | 0.74% |
| Financial Health | ||
| Profit Margin (TTM) | 0.03% | 0.13% |
| Operating Margin (TTM) | 0.04% | 0.16% |
| Return on Equity (TTM) | 0.09% | 0.17% |
| Debt to Equity (MRQ) | 64.36 | 77.58 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹146.47 | ₹56.20 |
| Cash per Share (MRQ) | ₹30.67 | ₹2.35 |
| Operating Cash Flow (TTM) | ₹3.31B | ₹-171,590,000 |
| Levered Free Cash Flow (TTM) | ₹1.50B | ₹117.48M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Medplus Health vs Trident Lifeline
| Metric | MEDPLUS | TLL |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 54.22 | 25.39 |
| Forward P/E | 53.18 | N/A |
| PEG Ratio | 53.18 | 0.28 |
| Price to Sales (TTM) | 1.56 | 3.29 |
| Price to Book (MRQ) | 5.49 | 4.93 |
| Market Capitalization | ||
| Market Capitalization | ₹96.37B | ₹3.21B |
| Enterprise Value | ₹103.80B | ₹3.46B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.68 | 3.56 |
| Enterprise to EBITDA | 29.79 | 19.53 |
| Risk & Other Metrics | ||
| Beta | 0.69 | -0.16 |
| Book Value per Share (MRQ) | ₹146.47 | ₹56.20 |
Financial Statements Comparison: Medplus Health vs Trident Lifeline
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | MEDPLUS | TLL |
|---|---|---|
| Revenue/Sales | ₹15.43B | ₹236.05M |
| Cost of Goods Sold | ₹11.40B | ₹109.46M |
| Gross Profit | ₹4.03B | ₹126.60M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹651.12M | ₹37.07M |
| EBITDA | ₹1.46B | ₹65.21M |
| Pre-Tax Income | ₹527.66M | ₹39.34M |
| Income Tax | ₹104.23M | ₹11.50M |
| Net Income (Profit) | ₹423.43M | ₹27.84M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | MEDPLUS | TLL |
|---|---|---|
| Cash & Equivalents | ₹860.52M | ₹24.61M |
| Total Current Assets | ₹18.44B | ₹903.71M |
| Total Current Liabilities | ₹5.77B | ₹535.55M |
| Long-Term Debt | ₹10.08B | ₹322.73M |
| Total Shareholders Equity | ₹17.40B | ₹696.50M |
| Retained Earnings | N/A | N/A |
| Property, Plant & Equipment | ₹12.49B | ₹349.63M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | MEDPLUS | TLL |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | MEDPLUS | TLL |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 358,057 | 14,220 |
| Average Daily Volume (90 Day) | 202,418 | 8,180 |
| Shares Outstanding | 119.64M | 11.50M |
| Float Shares | 69.21M | 3.48M |
| % Held by Insiders | 0.42% | 0.77% |
| % Held by Institutions | 0.35% | 0.00% |
Dividend Analysis & Yield Comparison: Medplus Health vs Trident Lifeline
| Metric | MEDPLUS | TLL |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |